Krug M, Folkers G, Haas B, Hess G, Wiesmüller K H, Freund S, Jung G
Biopolymers. 1989 Jan;28(1):499-512. doi: 10.1002/bip.360280144.
A novel synthetic foot-and-mouth disease virus (FMDV) peptide vaccine consisting of a synthetic B-cell and macrophage activator covalently linked to an amphiphilic alpha-helical T-cell epitope was developed. The low molecular weight vaccine of 3400 daltons is composed of virus VP1 antigenic determinant and the immunologically active lipotripeptide tripalmitoyl-S-glyceryl-cysteinyl-seryl-serine (P3CSS) as built-in adjuvant. The vaccine, tripalmitoyl-S-glyceryl-cysteinyl-seryl-seryl-FMDV-VP1 (VP1 = serotype O1K 135-154) induces protection against homologous challenge and serotype-specific virus neutralizing antibodies in guinea pigs after single administration without further adjuvants or carriers. A P3CSS conjugate with the FMDV-VP1 segment 135-154 of strain O Wuppertal produced only poor cross-protection against challenge with O1K virus. The antigenic determinant VP1(135-154) is an amphiphilic alpha-helix, as shown by CD. Molecular dynamics simulations (MDS) carried out using the highly homologous alpha-helical alcohol dehydrogenase (ADH) segment H3 as starting conformation for VP1(138-149) suggest that the FMDV segment 138-149 may adopt alpha-helical conformation during binding to its T-cell receptor, and that the development of the system during MDS may be considered as the dissociation step of the complex.
开发了一种新型合成口蹄疫病毒(FMDV)肽疫苗,该疫苗由与两亲性α-螺旋T细胞表位共价连接的合成B细胞和巨噬细胞激活剂组成。这种分子量为3400道尔顿的低分子量疫苗由病毒VP1抗原决定簇和具有免疫活性的脂三肽三棕榈酰-S-甘油基-半胱氨酰-丝氨酰-丝氨酸(P3CSS)作为内置佐剂组成。该疫苗,三棕榈酰-S-甘油基-半胱氨酰-丝氨酰-丝氨酰-FMDV-VP1(VP1 = O1K血清型135 - 154)在单次给药后,无需进一步的佐剂或载体,就能在豚鼠中诱导针对同源攻击的保护作用和血清型特异性病毒中和抗体。P3CSS与伍珀塔尔O株FMDV-VP1片段135 - 154的缀合物对O1K病毒攻击仅产生较差的交叉保护作用。如圆二色光谱所示,抗原决定簇VP1(135 - 154)是一种两亲性α-螺旋。使用高度同源的α-螺旋醇脱氢酶(ADH)片段H3作为VP1(138 - 149)的起始构象进行的分子动力学模拟(MDS)表明,FMDV片段138 - 149在与其T细胞受体结合过程中可能采用α-螺旋构象,并且MDS过程中系统的发展可被视为复合物的解离步骤。